Thiago P. Muniz
Toronto, ON M5S1A1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Body Composition and Melanoma Outcomes in Patients on Immunotherapy or Targeted Therapy: An Analysis from Canadian Melanoma Research Network.
Journal: Current oncology (Toronto, Ont.)
Published: April 17, 2026
Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.
Journal: Frontiers in oncology
Published: March 27, 2026
Temozolomide reconsidered: Real-World evidence in resistant melanoma cases.
Journal: The oncologist
Published: November 13, 2025
Female Oncofertility and Immune Checkpoint Blockade in Melanoma: Where Are We Today?
Journal: Cancers
Published: December 02, 2024
The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies.
Journal: Cancers
Published: November 12, 2023
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre.
Journal: Cancers
Published: August 02, 2023
Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
Journal: Journal of neuro-oncology
Published: June 22, 2023
BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.
Journal: CNS drugs
Published: May 16, 2023
Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center.
Journal: JCO oncology practice
Published: April 01, 2022
Last Updated: 09/26/2026